ctrl K

Angion Biomedica Corp. (ANGN)

NASDAQ: ANGN · Real-Time Price · USD

1.00

0.00 (0.00%)

At close: Jun 01, 2023, 8:00 PM

Angion Biomedica Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	2.3M	28.31M	2.88M	1.49M	4.03M
Cost of Revenue	n/a	433K	1.19M	640K	378K
Gross Profit	2.3M	27.88M	1.69M	847K	3.65M
Operating Income	-30.44M	-39.31M	-55.27M	-38.59M	-14.34M
Interest Income	n/a	n/a	n/a	265K	252K
Pretax Income	-38.81M	-54.57M	-80.11M	-40.66M	-20.02M
Net Income	-55.7M	-53.77M	-79.48M	-42.37M	-20.02M
Selling & General & Admin	14.64M	18.49M	17.99M	9.6M	5.39M
Research & Development	18.1M	48.7M	38.98M	29.84M	12.6M
Other Expenses	9.19M	-15.27M	-24.83M	-583K	n/a
Operating Expenses	32.74M	67.19M	56.96M	39.44M	17.99M
Interest Expense	805K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.74M	67.62M	58.15M	40.08M	18.37M
Income Tax Expense	16.89M	-801K	-628K	1.71M	-5.68M
Shares Outstanding (Basic)	30.04M	28.24M	28.78M	16.9M	15.36M
Shares Outstanding (Diluted)	30.04M	28.24M	28.78M	16.9M	15.36M
EPS (Basic)	-1.85	-1.9	-2.76	-2.51	-1.3
EPS (Diluted)	-1.85	-1.9	-2.76	-2.51	-1.3
EBITDA	-20.12M	-39.31M	-55.27M	-36.12M	-20.02M
EBIT	-28.82M	-56.42M	-88.95M	n/a	n/a
Depreciation & Amortization	10.32M	801K	628K	2.47M	2K